WWW.JNEUROSCI.ORG
-
The Journal of Neuroscience
 QUICK SEARCH:   [advanced]


     
-


HOME
  |  
SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

The Journal of Neuroscience, January 2, 2008, 28(1):68-79; doi:10.1523/JNEUROSCI.3080-07.2008

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Related articles in J. Neurosci.
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (13)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Du, J.
Right arrow Articles by Manji, H. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Du, J.
Right arrow Articles by Manji, H. K.

 Previous Article  |  Next Article 

Behavioral/Systems/Cognitive
The Role of Hippocampal GluR1 and GluR2 Receptors in Manic-Like Behavior

Jing Du,1 Thomas K. Creson,1 Long-Jun Wu,2 Ming Ren,2 Neil A. Gray,1 Cynthia Falke,1 Yanling Wei,1 Yun Wang,1 Rayah Blumenthal,1 Rodrigo Machado-Vieira,1 Peixiong Yuan,1 Guang Chen,1 Min Zhuo,2 and Husseini K. Manji1

1Laboratory of Molecular Pathophysiology, Mood and Anxiety Disorders Program, National Institute of Mental Health, National Institutes of Health, Bethesda, Maryland 20878, and 2Department of Physiology, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada M5S 1A8

Correspondence should be addressed to Dr. Husseini K. Manji, Laboratory of Molecular Pathophysiology, Mood and Anxiety Disorders Program, National Institute of Mental Health, 9000 Rockville Pike, Building 35, 1C912, Bethesda, MD 20892. Email: manji{at}nih.gov

The cellular basis underlying the complex clinical symptomatology of bipolar disorder and the mechanisms underlying the actions of its effective treatments have not yet been fully elucidated. This study investigated the role of hippocampal synaptic AMPA receptors. We found that chronic administration of the antimanic agents lithium and valproate (VPA) reduced synaptic AMPA receptor GluR1/2 in hippocampal neurons in vitro and in vivo. Electrophysiological studies confirmed that the AMPA/NMDA ratio was reduced in CA1 regions of hippocampal slices from lithium-treated animals. Reduction in GluR1 phosphorylation at its cAMP-dependent protein kinase A site by the synthetic peptide TAT-S845, which mimics the effects of lithium or VPA, was sufficient to attenuate surface and synaptic GluR1/2 levels in hippocampal neurons in vitro and in vivo. Intrahippocampal infusion studies with the AMPA-specific inhibitor GYKI 52466 [4-(8-methyl-9H-1,3-dioxolo[4,5-h][2,3]benzodiazepin-5-yl)-benzenamine hydrochloride], a GluR1-specific TAT-S845 peptide, showed that GluR1/2 was essential for the development of manic/hedonic-like behaviors such as amphetamine-induced hyperactivity. These studies provide novel insights into the role of hippocampal GluR1/2 receptors in mediating facets of the manic syndrome and offer avenues for the development of novel therapeutics for these disorders.

Key words: lithium; valproate; AMPA; PKA; phosphorylation; manic-like behavior


Received July 6, 2007; revised Oct. 15, 2007; accepted Nov. 2, 2007.

Correspondence should be addressed to Dr. Husseini K. Manji, Laboratory of Molecular Pathophysiology, Mood and Anxiety Disorders Program, National Institute of Mental Health, 9000 Rockville Pike, Building 35, 1C912, Bethesda, MD 20892. Email: manji{at}nih.gov


Related articles in J. Neurosci.:

This Week in The Journal

J. Neurosci. 2008 28: i. [Full Text]  



This article has been cited by other articles:


Home page
Mol. Pharmacol.Home page
S.-C. Mao, H.-C. Lin, and P.-W. Gean
Augmentation of Fear Extinction by Infusion of Glycine Transporter Blockers into the Amygdala
Mol. Pharmacol., August 1, 2009; 76(2): 369 - 378.
[Abstract] [Full Text] [PDF]


Home page
Am. J. PsychiatryHome page
R. H. Perlis, J. W. Smoller, M. A.R. Ferreira, A. McQuillin, N. Bass, J. Lawrence, G. S. Sachs, V. Nimgaonkar, E. M. Scolnick, H. Gurling, et al.
A Genomewide Association Study of Response to Lithium for Prevention of Recurrence in Bipolar Disorder
Am J Psychiatry, June 1, 2009; 166(6): 718 - 725.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
J. Du, Y. Wang, R. Hunter, Y. Wei, R. Blumenthal, C. Falke, R. Khairova, R. Zhou, P. Yuan, R. Machado-Vieira, et al.
Dynamic regulation of mitochondrial function by glucocorticoids
PNAS, March 3, 2009; 106(9): 3543 - 3548.
[Abstract] [Full Text] [PDF]



-
-

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help

-
Copyright 2009 by Society for Neuroscience ONLINE ISSN: 1529-2401
-